Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for AMGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 1988. Start Trial.
Date Value
December 31, 2025 9.129B
December 31, 2024 11.97B
December 31, 2023 10.94B
December 31, 2022 9.305B
December 31, 2021 8.037B
December 31, 2020 10.65B
December 31, 2019 8.911B
December 31, 2018 29.30B
December 31, 2017 41.68B
December 31, 2016 38.08B
December 31, 2015 31.38B
December 31, 2014 27.03B
December 31, 2013 19.40B
December 31, 2012 24.06B
December 31, 2011 20.64B
December 31, 2010 17.42B
December 31, 2009 13.44B
December 31, 2008 9.552B
December 31, 2007 7.151B
December 31, 2006 6.277B
Date Value
December 31, 2005 5.255B
December 31, 2004 5.808B
December 31, 2003 5.123B
December 31, 2002 4.664B
December 31, 2001 2.662B
December 31, 2000 2.028B
December 31, 1999 1.333B
December 31, 1998 1.276B
December 31, 1997 1.026B
December 31, 1996 1.077B
December 31, 1995 1.050B
December 31, 1994 696.68M
December 31, 1993 723.18M
December 31, 1992 555.41M
December 31, 1991 377.77M
March 31, 1991
March 31, 1990 80.02M
March 31, 1989 66.48M
March 31, 1988 105.56M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Gilead Sciences, Inc. 9.613B
Regeneron Pharmaceuticals, Inc. 8.611B
AbbVie, Inc. 5.257B
Biogen, Inc. 3.816B
Vertex Pharmaceuticals, Inc. 6.611B